Deparment A
Odense, 5000, Denmark
NCT Number: NCT00271986
Anastomotic leakage is a serious complication after LAR with high morbidity and mortality rates. Early diagnosis and treatment is mandatory. The primary aim of the present study is to investigate the clinical use of peritoneal microdialysis and whether is able to detect anastomotic leakage prior to clinical symptoms develops.
Looking for future studies?
Notify MeAll sexes
Observational
Odense, 5000, Denmark
Patients undergoing LAR for recto-sigmoid cancer is subjected to peritoneal microdialyses during the postoperative period until discharge. Subcutaneous microdialysis serve as control. Samples are collected every 4-hour. Samples will be analyzed continuously but the results will not be included in the clinical evaluation of the patient.
Patients undergoing abdomino-perineal rectal resection will serve as a control group.
A total of 50 patients will be included in this pilot study. The results of the peritoneal microdialyses will be compared with the clinical course in each patient. The results form the uncomplicated courses will be used to define the normal variations in peritoneal microdialysis. This will be compared to results from patients with various complications.
The study is approved by the local scientific ethical committee No. ------
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: within 30 days
Odense University Hospital
Other
Intraperitoneal Microdialysis Monitoring of Patients During the Early Postoperative Period After LAR With Reference to Early Diagnosis of Anastomotic Leakage
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05887531
Adnexal Diseases, Cancer of Colon
Castellon, Castellón, Spain
View Trial DetailsNCT03133286
Adnexal Diseases, Anus Diseases
Compton, California, United States
View Trial DetailsNCT04880772
Cancer of Colon, Cancer of Rectum
Blackburn, United Kingdom
View Trial DetailsNCT04716010
Cancer of Colon, Cancer of Rectum
Chapel Hill, North Carolina, United States
View Trial Details